Skip to main content
Clinical Trials/NCT00773565
NCT00773565
Completed
Not Applicable

Identification of Novel Targets for Regulation of Adipose Tissue Mass

Gottfried Rudofsky1 site in 1 country62 target enrollmentOctober 2008
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Gottfried Rudofsky
Enrollment
62
Locations
1
Primary Endpoint
number of adipocytes and preadipocytes under weight loss
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The aim of this study is to understand the metabolic changes occurring in fat tissue both during controlled weight loss that lead to the improvement of type 2 diabetes and other obesity associated metabolic disorders. The novelty of the study is the analysis of preadipocytes, a poorly characterized subfraction of the adipose tissue, which provides adipocyte precursors and thereby strongly influences adipose tissue mass changes. Knowledge of pathways involved in controlling adipose tissue composition will help to design novel intervention strategies for the treatment of obesity associated metabolic disorders such as type 2 diabetes.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
August 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Gottfried Rudofsky
Responsible Party
Sponsor Investigator
Principal Investigator

Gottfried Rudofsky

Oberarzt

Heidelberg University

Eligibility Criteria

Inclusion Criteria

  • Participants of the OPTIFAST52 program
  • BMI \> 30 kg/m2

Exclusion Criteria

  • Rejection of informed consent by the participant

Outcomes

Primary Outcomes

number of adipocytes and preadipocytes under weight loss

Time Frame: three years

Secondary Outcomes

  • metabolic function of adipocytes and preadipocytes under weight loss(three years)

Study Sites (1)

Loading locations...

Similar Trials